FDA recall D-0884-2022

Product

Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

Reason for recall

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions

Distribution

NM only

Key facts

Status

Completed

Initiation date

2022-04-05

Report date

2022-05-25

Voluntary/Mandated

Voluntary: Firm initiated

Location

Dublin, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0884-2022